Diagnostic criteria for minimally differentiated acute myeloid leukemia (AML-MO)

American Journal of Clinical Pathology

Volumn 115, Issue 6, 2001, Pages 876-884

  Kaleem, Zahid ^a   White, Glenda ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute myeloid leukemia; AML MO; Cytogenetics; FAB MO; Flow cytometry; Immunohistochemistry; Immunophenotyping

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD79A ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; DNA NUCLEOTIDYLEXOTRANSFERASE; HLA DR ANTIGEN; MICROSOMAL AMINOPEPTIDASE; MYELOPEROXIDASE; T LYMPHOCYTE ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CANCER DIAGNOSIS; CELL LINEAGE; CHILD; CLINICAL ARTICLE; CYTOCHEMISTRY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CHILD; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; KARYOTYPING; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; PEROXIDASE;

EID: 0035001114     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/D2BR-C0V5-LEYD-HA2D     Document Type: Article

References (34)

1. Bennett JM, Catovsky D, Daniel MT, et al, for the French-American-British (FAB) Cooperative Group. Proposals for the classification of the acute leukemias. Br J Haematol. 1976;53:451-458.
2. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the recognition of minimally differentiated acute myeloid leukemia (AML-M0). Br J Haematol. 1991;78:325-329.
3. Iwate H, Kami M, Kishi Y, et al. Limitations of the diagnostic criteria for minimally differentiated acute myeloid leukemia (AML-MO). Leukemia. 2000;14;2013-2014.
4. Childs C, Hirsch-Ginsberg C, Walters RS, et al. Myeloid surface antigen-positive acute lymphoblastic leukemia (My+ ALL): immunophenotypic, ultrastructural, cytogenetic and molecular characteristics. Leukemia. 1989;3:777-783.
5. Yokose N, Ogata K, Ito T, et al. Chemotherapy for minimally differentiated acute myeloid leukemia: a report of five cases and review of the literature. Ann Hematol. 1993;66:67-70.
6. Stasi R, Del Poeta G, Venditti A, et al. Analysis of treatment failure in patients with minimally differentiated acute myelogenous leukemia (AML-M0). Blood. 1994;83:1619-1625.
7. Cuneo A, Ferrant A, Michauz JL, et al. Cytogenetic profile of minimally differentiated (FAB-M0) acute myeloid leukemia: correlation with clinicopathologic findings. Blood. 1995;85:3688-3694.
8. Kotylo PK, Seo I-S, Smith FO, et al. Flow cytometric immunophenotypic characterization of pediatric and adult minimally differentiated acute myeloid leukemia (AML-M0). Am J Clin Pathol. 2000;113:193-200.
9. Lee EJ, Pollak A, Leavitt RD, et al. Minimally differentiated acute non-lymphocytic leukemia: a distinct entity. Blood. 1987;70:1400-1406.
10. Matutes E, DeOliveira MP, Foroni L, et al. The role of ultrastructural cytochemistry and monoclonal antibodies in clarifying the nature of undifferentiated cells in acute leukemia. Br J Haematol. 1988;69:205-211.
11. Campos L, Guyotat D, Archimbaud E, et al. Surface marker expression in adult acute myeloid leukemia: correlations with initial characteristics, morphology and response to therapy. Br J Haematol. 1989;72:161-166.
12. Keenan FM, Barnett D, Reilly JT. Clinicopathologic features of minimally differentiated acute myeloid leukemia (AML-M0). Br J Haematol. 1992;81:458-459.
13. Buccheri V, Shetty V, Yoshida N, et al. The role of an anti-myeloperoxidase antibody in the diagnosis and classification of acute leukemia: a comparison with light and electron microscopy cytochemistry. Br J Haematol. 1992;80:62-68.
14. Sempere A, Jarque L, Guinot M, et al. Acute myeloblastic leukemia with minimal myeloid differentiation (FAB AML-M0): a study of eleven cases. Leuk Lymphoma. 1993;12:103-106.
15. Venditti A, Del Poeta G, Stasi R, et al. Minimally differentiated acute myeloid leukemia (AML-M0): cytochemical, immunophenotypic and cytogenetic analysis of 19 cases. Br J Haematol. 1994;88:784-793.
16. Segeren CM, de Jong-Gerrits GC, van't Veer MB, et al. AML-M0: clinical entity or waste basket for immature blastic leukemias? a description of 14 patients. Ann Hematol. 1995;70:297-300.
17. Creutzig U, Harbott J, Sperling C, et al. Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87. Blood. 1995; 86:3097-3108.
18. Villamor N, Zarco M-A, Rozman M, et al. Acute myeloblastic leukemia with minimal myeloid differentiation: phenotypical and ultrastructural characteristics. Leukemia. 1998;12:1071-1075.
19. Cohen PL, Hoyer JD, Kurtin PJ, et al. Acute myeloid leukemia with minimal differentiation: a multiple parameter study. Am J Clin Pathol. 1998;109:32-38.
20. Wiersma S, Ortega J, Sobel E, et al. Clinical significance of myeloid-associated antigen expression in acute lymphoblastic leukemia of childhood. N Engl J Med. 1991;324:800-808.
21. Van Dongen JJM, Adriaansen HJ. Immunobiology of leukemia. In: Henderson ES, Lister TA, Greaves MF, eds. Leukemia. 2nd ed. Philadelphia, PA: Saunders; 1996:83-130.
22. Parreira A, Pombo de Oliveira MS, Matutes E, et al. Terminal deoxynucleotidyl transferase positive acute myeloid leukaemia: an association with immature myeloblastic leukaemia. Br J Haematol. 1988;69:219-224.
23. Saito T, Yamazaki T. CD3 workshop panel report. In: Kishimoto T, Kikutani H, von dem Borne AEG, et al, eds. Leukocyte Typing VI: White Cell Differentiation Antigens. New York, NY: Garland Publishing; 1998:44-48.
24. Bowen MA. CD7 workshop panel report. In: Kishimoto T, Kikutani H, von dem Borne AEG, et al, eds. Leukocyte Typing VI: White Cell Differentiation Antigens. New York, NY: Garland Publishing; 1998:62-63.
25. Sato S, Tedder TF. CD19 workshop panel report. In: Kishimoto T, Kikutani H, von dem Borne AEG, et al, eds. Leukocyte Typing VI: White Cell Differentiation Antigens. New York, NY: Garland Publishing; 1998:133-134.
26. Nakamura T. CD79 workshop panel report. In: Kishimoto T, Kikutani H, von dem Borne AEG, et al, eds. Leukocyte Typing VI: White Cell Differentiation Antigens. New York, NY: Garland Publishing; 1998:180-182.
27. Shaw S. CD Guide. In: Kishimoto T, Kikutani H, von dem Borne AEG, et al, eds. Leukocyte Typing VI: White Cell Differentiation Antigens. New York, NY: Garland Publishing; 1998:1109-1220.
28. Goasguen JE, Bennett JM, Henderson ES. Biologic diagnosis of leukemia. In: Henderson ES, Lister TA, Greaves MF, eds. Leukemia. 2nd ed. Philadelphia, PA: Saunders; 1996:8-33.
29. Ferrari S, Mariano MT, Tagliafico E, et al. Myeloperoxidase gene expression in blast cells with a lymphoid phenotype in cases of acute lymphoblastic leukemia. Blood. 1998;72:873-876.
30. Zhou M, Findley HW, Zaki SR, et al. Expression of myeloperoxidase mRNA by leukemia cells from childhood acute lymphoblastic leukemia. Leukemia. 1993;7:1180-1183.
31. Serrano J, Roman J, Sanchez J, et al. Myeloperoxidase gene expression in acute lymphoblastic leukaemia. Br J Haematol. 1997;97:841-843.
32. Crisan D, Topalovski M, O'Malley B. Myeloperoxidase mRNA analysis in acute lymphoblastic leukemia. Diagn Mol Pathol. 1996;5:236-248.
33. Imamura N. Sensitive detection technique of myeloperoxidase precursor protein by flow cytometry with monoclonal antibodies. Am J Hematol. 1998;58:241-243.
34. Stasi R, Amadori S. AML-M0: a review of laboratory features and proposal of new diagnostic criteria. Blood Cells Mol Dis. 1999;25:120-129.